These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27362371)

  • 1. Current Concepts and Controversies in Innate Immunity of Cystic Fibrosis Lung Disease.
    Ralhan A; Laval J; Lelis F; Ballbach M; Grund C; Hector A; Hartl D
    J Innate Immun; 2016; 8(6):531-540. PubMed ID: 27362371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts of immune dysregulation in cystic fibrosis.
    Rieber N; Hector A; Carevic M; Hartl D
    Int J Biochem Cell Biol; 2014 Jul; 52():108-12. PubMed ID: 24495876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease.
    Tucker SL; Sarr D; Rada B
    BMC Immunol; 2021 Jan; 22(1):7. PubMed ID: 33478382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis.
    Bingle L; Barnes FA; Cross SS; Rassl D; Wallace WA; Campos MA; Bingle CD
    Respir Res; 2007 Nov; 8(1):79. PubMed ID: 17988392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.
    Guan X; Hou Y; Sun F; Yang Z; Li C
    Curr Drug Targets; 2016; 17(13):1535-44. PubMed ID: 26648071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pulmonary inflammation and lung damage in children with cystic fibrosis.
    Schultz A; Stick S
    Respirology; 2015 May; 20(4):569-78. PubMed ID: 25823858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and Adaptive Immunity in Cystic Fibrosis.
    Bruscia EM; Bonfield TL
    Clin Chest Med; 2016 Mar; 37(1):17-29. PubMed ID: 26857765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity in cystic fibrosis lung disease.
    Hartl D; Gaggar A; Bruscia E; Hector A; Marcos V; Jung A; Greene C; McElvaney G; Mall M; Döring G
    J Cyst Fibros; 2012 Sep; 11(5):363-82. PubMed ID: 22917571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical activation of the unfolded protein response in cystic fibrosis airway cells contributes to p38 MAPK-mediated innate immune responses.
    Blohmke CJ; Mayer ML; Tang AC; Hirschfeld AF; Fjell CD; Sze MA; Falsafi R; Wang S; Hsu K; Chilvers MA; Hogg JC; Hancock RE; Turvey SE
    J Immunol; 2012 Dec; 189(11):5467-75. PubMed ID: 23105139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
    Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting defective pulmonary innate immunity - A new therapeutic option?
    Belchamber KBR; Donnelly LE
    Pharmacol Ther; 2020 May; 209():107500. PubMed ID: 32061706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity.
    Laucirica DR; Garratt LW; Kicic A
    Front Immunol; 2020; 11():595. PubMed ID: 32318073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis.
    Cabrini G; Rimessi A; Borgatti M; Lampronti I; Finotti A; Pinton P; Gambari R
    Front Immunol; 2020; 11():1438. PubMed ID: 32849500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic Fibrosis Lung Immunity: The Role of the Macrophage.
    Bruscia EM; Bonfield TL
    J Innate Immun; 2016; 8(6):550-563. PubMed ID: 27336915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis.
    Lammertyn EJ; Vandermeulen E; Bellon H; Everaerts S; Verleden SE; Van Den Eynde K; Bracke KR; Brusselle GG; Goeminne PC; Verbeken EK; Vanaudenaerde BM; Dupont LJ
    Respir Res; 2017 Jan; 18(1):10. PubMed ID: 28069067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease.
    Blohmke CJ; Victor RE; Hirschfeld AF; Elias IM; Hancock DG; Lane CR; Davidson AG; Wilcox PG; Smith KD; Overhage J; Hancock RE; Turvey SE
    J Immunol; 2008 Jun; 180(11):7764-73. PubMed ID: 18490781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune response in CF airway epithelia: hyperinflammatory?
    Machen TE
    Am J Physiol Cell Physiol; 2006 Aug; 291(2):C218-30. PubMed ID: 16825601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CF monocyte-derived macrophages have an attenuated response to extracellular vesicles secreted by airway epithelial cells.
    Koeppen K; Nymon A; Barnaby R; Li Z; Hampton TH; Ashare A; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2021 Apr; 320(4):L530-L544. PubMed ID: 33471607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.
    Cantin AM; Hartl D; Konstan MW; Chmiel JF
    J Cyst Fibros; 2015 Jul; 14(4):419-30. PubMed ID: 25814049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.